Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma (OPTIC)

NCT05514912 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05514912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma (OPTIC)
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Withdrawn
Start date
March 1, 2024
Completion date
June 23, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

resectable intrahepatic cholangiocarcinoma, stage 0 intrahepatic cholangiocarcinoma ajcc v8, stage i intrahepatic cholangiocarcinoma ajcc v8, stage ii intrahepatic cholangiocarcinoma ajcc v8, stage iii intrahepatic cholangiocarcinoma ajcc v8